Omega-3 fatty acids may inhibit prostate cancer cell growth
the ONA take:
In contradiction to a 2013 study, researchers have found a mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells. The new study was published in the Journal of Pharmacology and Experimental Therapeutics.
Kathryn Meier, PhD, and two students at Washington State University looked at prostate cell cultures and found that fatty acids are able to bind to FFA4, the “free fatty acid receptor 4”, which inhibits growth factors and suppresses the spread of cancer cells.
“This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works,” Dr. Meier said.
This study contrasts with a 2013 study published in the Journal of the National Cancer Institute which found that men with higher levels of omega-3 fatty acids in their blood had a greater risk of developing prostate cancer.
However, it is still unclear if the effect can be obtained through dietary supplements, and that the drug needs to be in a cancer cell constantly in order to take effect.
A mechanism in omega-3 fatty acids may inhibit the growth and spread of prostate cancer cells.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|